Related Experiment Video
Updated: Feb 10, 2026

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
Removing barriers to a clinical pharmacogenetics service
William Newman1, Katherine Payne2
1University of Manchester and Regional Genetics Service, Department of Medical Genetics, St Mary's Hospital, Manchester, M13 0JH, UK. william.newman@manchester.ac.uk.
Pharmacogenetics, the study of how genes affect drug response, can improve medication safety and effectiveness. Despite slow adoption, robust evidence shows its potential to reduce adverse drug reactions, highlighting the need for effective implementation strategies.
Area of Science:
- Pharmacology
- Genetics
- Clinical Medicine
Background:
- Pharmacogenetics offers potential for personalized medicine by predicting drug response and side effects.
- Implementation of pharmacogenetic testing in clinical practice has faced challenges and slow adoption.
- Recent evidence supports the efficacy of pharmacogenetics in minimizing adverse drug reactions.
Purpose of the Study:
- To explore factors influencing the integration of pharmacogenetics into routine clinical practice.
- To define requirements for establishing effective, safe, efficient, and equitable pharmacogenetics services.
Main Methods:
- Review of recent studies and clinical evidence.
- Analysis of barriers and facilitators for pharmacogenetics implementation.
- Discussion of essential components for a successful pharmacogenetics service.
Main Results:
- Pharmacogenetics can significantly reduce adverse drug reactions.
- Several factors influence the clinical uptake of pharmacogenetic testing.
- Key requirements for service implementation include safety, efficacy, and equity.
Conclusions:
- Pharmacogenetics holds significant promise for safer and more effective prescribing.
- Addressing implementation challenges is crucial for realizing the full potential of pharmacogenetics.
- A well-defined framework is necessary for equitable and efficient pharmacogenetics services.
More Related Videos
Related Concept Videos
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Preventive Healthcare Services
Physiological Barriers
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Barriers to Effective Communication II
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

